Last reviewed · How we verify
NCT03605290
Comparison Between Two Operational Techniques for Total Knee Replacement
NA trial testing REHAGAIT ANYLIZER in Gait, Unsteady in 26 participants. Completed in 1 January 2020.
1 January 2020
Quick facts
| Lead sponsor | HaEmek Medical Center, Israel |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | diagnostic |
| Enrollment | 26 |
| Start date | 15 June 2018 |
| Primary completion | 1 January 2020 |
| Estimated completion | 1 January 2020 |
| Sites | 1 location across Israel |
Drugs / interventions tested
- REHAGAIT ANYLIZER
Conditions studied
- Gait, Unsteady — all drugs for Gait, Unsteady →
- Knee Arthropathy — all drugs for Knee Arthropathy →
- Surgery — all drugs for Surgery →
Sponsor
HaEmek Medical Center, Israel
Who can join
Adults 50 to 80, any sex, with Gait, Unsteady or Knee Arthropathy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Advance Knee osteoarthritis is treated by Total knee replacement. Since the first TKR in 1973 there has been continuous advance in implant technology as well as operative technique, yet current patient satisfaction after the procedure is accepted to be about 80%. There are a few operative techniques to perform TKR. Until recently the most common technique is the anterior approach to the knee and then using mechanical instrumentation to make the bone cuts for the femur and tibia. A second popular technique is the anterior approach to the knee and then using a kinematic alignment to make the bone cuts. The investigators wish to compare short term results of the two operative techniques as evidenced in patient objective functional scores and also by evaluating the gait of the patients by using the REHAGAIT ANALYZER PRO by HASOMED inc. Magdeburg Germany.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03605290
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other HaEmek Medical Center, Israel trials
Trials by the same sponsor.
- NCT06656286 — Hysteroscopic Intrauterine Suturing · NA · not yet recruiting
- NCT06803992 — Induction of Labor - Comparison Propess With Prostaglandin E2 Vaginal Gel and Balloon Catheter · Phase 4 · recruiting
- NCT06542367 — Trans Canal Tympanoplasty With Local Anesthesia Using Fat Graft and "TachoSil" · NA · not yet recruiting
- NCT05732155 — Preliminary Effectiveness of Individual and Group MDMA-assisted Therapy for Israeli Veterans With PTSD and Moral Injury. · Phase 2 · unknown
- NCT05933018 — Night Hyperglycemia and Fatty Liver in Type 1 Diabetes · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03605290 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by HaEmek Medical Center, Israel
- Last refreshed: 12 February 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03605290.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing